{
  "drug_name": "Ampicillin-sulbactam",
  "tradename": "Unasyn",
  "usage_and_dosing": {
    "general": [
      "Ampicillin-sulbactam is an aminopenicillin combined with a beta-lactamase inhibitor.",
      "A broad spectrum of activity allows use for many types of infections; e.g., appendicitis, diverticulitis, peritonitis. Increasing resistance, however, hampers use against aerobic gram-negative bacilli.",
      "Guidelines have dropped Ampicillin-Sulbactam for empiric use in intraabdominal infections due to increasing resistance of aerobic gram-negative bacilli.",
      "Total daily dose of Sulbactam is ≤4 gm for aerobic gram-negative bacilli. The Sulbactam component has useful activity against Acinetobacter baumannii, but is given in higher doses for this indication and usually as part of combination therapy.",
      "Doses expressed as the sum of the components, thus 3 gm = Ampicillin 2 gm + Sulbactam 1 gm (2:1 ratio)."
    ],
    "adult_dose": {
      "usual_dose": "3 gm IV (over 30 min) q6h",
      "other_dosing": "Refer to these pages: Pneumonia, Acinetobacter sp., Acinetobacter baumannii-calcoac"
    },
    "pediatric_dose": {
        "note": "Doses expressed as sum of ampicillin + sulbactam (2:1 ratio)",
        "amr_gram_negative_guidance": "J Pediatric Infect Dis Soc 2025;14:piaf004",
        "per_red_book": {
            "age_gt_28_days": "150-300 mg/kg/day (divided q6h)",
            "meningitis": "600 mg/kg/day (divided q6h)"
        },
        "per_amr_guidance": {
            "neonates": "PNA ≤7 days: 450 mg/kg/day (div q8h, infused over 4 hr). PNA 8-60 days: 450 mg/kg/day (div q6h, infused over 4 hr)",
            "infants_and_children": "600 mg/kg/day (div q4-6h, infused over 4 hr, max 18 gm/day)",
            "adolescents_ge_12_yrs": "9 gm/day sulbactam via 1 of 2 regimens: 9 gm amp/sulb (over 4 hr) q8h, OR 27 gm amp/sulb (continuous 24-hr infusion)",
            "cns_note": "Note: infusions of ≤1 hr suggested for CNS infections"
        },
        "max_day": "12 gm (unless otherwise specified)"
    }
  },
  "renal_adjustment": {
    "half_life_normal": "Ampicillin: 1.4, Sulbactam: 1.7",
    "half_life_esrd": "Ampicillin: 7-20, Sulbactam: 10",
    "dose_renal_function_normal": "1.5-3 gm IV q6h",
    "crcl_or_egfr": "CrCl ≥30: No dosage adjustment. CrCl 15-29: 1.5-3 gm q12h. CrCl 5-14: 1.5-3 gm q24h",
    "hemodialysis": "1.5-3 gm q24h (give AD on dialysis day)",
    "capd": "3 gm q24h",
    "crrt": "1.5-3 gm q8-12h",
    "sled": "3 gm q12h 32"
  },
  "hepatic_adjustment": {
    "mild_impairment_child_pugh_a": "No data",
    "moderate_impairment_child_pugh_b": "No data",
    "severe_impairment_child_pugh_c": "No data"
  },
  "adverse_effects": [
    "GI (nausea/vomiting, diarrhea (2%), C. difficile colitis)",
    "Hypersensitivity: rash (2%), fever, anaphylaxis",
    "A maculopapular rash occurs (not urticarial), not true penicillin allergy, in 65–100% patients with infectious mononucleosis, 90% with chronic lymphocytic leukemia, and 15-20% with allopurinol therapy.",
    "Local phlebitis (3%)",
    "Hematologic: neutropenia, eosinophilia (22%), thrombocytopenia",
    "Increased LFTs (6%)",
    "Rare: increased BUN/Scr, headache, confusion"
  ],
  "pregnancy_risk": {
    "fda_risk_category": "No evidence of toxicity in humans or animals",
    "lactation": "Milk concentrations low, adverse effects not expected. Monitor infant for GI toxicity.",
    "footnote": "Capital letter = Old FDA risk category; Text = New FDA risk category"
  },
  "antimicrobial_spectrum": {
    "preferred": [
        "Haemophilus influenzae",
        "Pasteurella multocida"
    ],
    "alternative": []
  },
  "pharmacology": {
    "pk_pd_index": "T>MIC",
    "preparations": "Injection",
    "food_recommendation": null,
    "oral_absorption_percent": null,
    "tmax_hr": null,
    "peak_serum_conc_ug_ml": "Ampicillin 109-150, Sulbactam 48-88 (3 gm IV, SD)",
    "peak_urine_conc_ug_ml": "No data",
    "protein_binding_percent": "Ampicillin: 28, Sulbactam: 38",
    "volume_of_distribution_vd_l_kg": "Ampicillin: 0.29 L/kg, Sulbactam: 0.3 L/kg",
    "avg_serum_half_life_hr": "Ampicillin: 1.4, Sulbactam: 1.7",
    "elimination": "Renal",
    "bile_penetration_percent": "Ampicillin: 100-3000",
    "csf_blood_percent": "No data",
    "therapeutic_levels_in_csf": "No data",
    "auc_ug_hr_ml": "Ampicillin 120, Sulbactam 71 (3 gm IV, 0-inf)"
  },
  "enzyme_transporter_mediated_interactions": {
      "cyp450s_substrate": [],
      "transporters_substrate": "Ampicillin: OAT1, OAT3, Sulbactam: OAT1, OAT3",
      "ugts_substrate": [],
      "cyp450s_inhibited": [],
      "transporters_inhibited": [],
      "ugts_inhibited": [],
      "cyp450s_induced": [],
      "transporters_induced": [],
      "ugts_induced": [],
      "impact_on_serum_drug_concentrations": "None expected"
  },
  "major_drug_interactions": [
      {"drug": "Allopurinol", "effect": "↑ frequency of rash", "management": "Monitor"},
      {"drug": "Probenecid", "effect": "↑ ampicillin", "management": "Monitor, adjust dosage"}
  ]
}
